77 related articles for article (PubMed ID: 12750694)
1. Prognostic implications of epigenetic silencing of p15INK4B in acute promyelocytic leukemia.
Garcia-Manero G
Leukemia; 2003 May; 17(5):839-40. PubMed ID: 12750694
[No Abstract] [Full Text] [Related]
2. Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis.
Teofili L; Martini M; Luongo M; Diverio D; Capelli G; Breccia M; Lo Coco F; Leone G; Larocca LM
Leukemia; 2003 May; 17(5):919-24. PubMed ID: 12750706
[TBL] [Abstract][Full Text] [Related]
3. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
4. Detection of aberrant methylation of the p15INK4B gene promoter.
Uchida T
Methods Mol Med; 2002; 68():239-49. PubMed ID: 11901506
[No Abstract] [Full Text] [Related]
5. Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes.
Aoki E; Ohashi H; Uchida T; Murate T; Saito H; Kinoshita T
Leukemia; 2003 Sep; 17(9):1903-4. PubMed ID: 12970793
[No Abstract] [Full Text] [Related]
6. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
8. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
10. Different prognostic values of p15(INK4b) and p16(INK4a) gene methylations in multiple myeloma.
Guillerm G; Depil S; Wolowiec D; Quesnel B
Haematologica; 2003 Apr; 88(4):476-8. PubMed ID: 12681979
[No Abstract] [Full Text] [Related]
11. Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML).
Tessema M; Länger F; Dingemann J; Ganser A; Kreipe H; Lehmann U
Leukemia; 2003 May; 17(5):910-8. PubMed ID: 12750705
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
[TBL] [Abstract][Full Text] [Related]
13. p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.
Kusy S; Cividin M; Sorel N; Brizard F; Guilhot F; Brizard A; Larsen C; Roche J
Blood; 2003 Jan; 101(1):374-5. PubMed ID: 12485942
[No Abstract] [Full Text] [Related]
14. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
15. [Detection of hypermethylation of p15 gene in patients with acute leukemia by polymerase chain reaction].
Chen F; Zeng X
Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):250-2. PubMed ID: 11876990
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?
Lübbert M
Leukemia; 2003 Sep; 17(9):1762-4. PubMed ID: 12970776
[No Abstract] [Full Text] [Related]
17. [Homozygous deletion and methylation of p16 and p15 gene in acute leukemia].
Chen W; Zhang W; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):474-6. PubMed ID: 11721412
[TBL] [Abstract][Full Text] [Related]
18. Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas.
García MJ; Martínez-Delgado B; Cebrian A; Martínez A; Benítez J; Rivas C
Am J Pathol; 2002 Sep; 161(3):1007-13. PubMed ID: 12213729
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
[TBL] [Abstract][Full Text] [Related]
20. p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia.
Kusy S; Larsen CJ; Roche J
Leuk Lymphoma; 2004 Oct; 45(10):1989-94. PubMed ID: 15370242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
